Molecular-biological problems of drug design and mechanism of drug action - Pharmacokinetic study of the new domestic hypodermic form of naltrexone: Prodetoxon depot tablets

Pharmaceutical Chemistry Journal

Volumn 39, Issue 1, 2005, Pages 1-3

  Ramenskaya, G V ^a,b   Shikh, E V ^a,b   Arzamastsev, A P ^a,b   Kukes, V G ^a,b  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Federal State Budgetary Institution Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 3 METHOXY 6 BETA NATREXOL; 6 BETA NALTREXOL; NALTREXOL; NALTREXONE; PRODETOXON; UNCLASSIFIED DRUG;

ARTICLE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMPLANTATION; PLASMA; TABLET;

EID: 21544436595     PISSN: 0091150X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11094-005-0066-3     Document Type: Article

References (5)

1. V. M. Bulaev, Advances in Science. Pharmacology [in Russian], VINITI, Moscow (1982), Vol. 13, pp. 101-184.
2. B. J. Berg, H. M. Pettinati, J. R. Volpicelli, Drug Safety, 4, 272-282 (1996).
3. T. Reisine and G. Pasternak, in: Pharmacological Basis of Therapies, Goodman & Gilman, New York (1995), pp. 521-564.
4. R. M. Swift, J. Clin. Psychiatry, 56, 24-29 (1995).
5. J. R. Volpicelli, et al., Arch. Gen. Psychiatry, 49, 876-880 (1992).